Nutex Health (NUTX) Equity Average (2011 - 2026)

Nutex Health's Equity Average history runs 15 years deep, the most recent figure standing at $432.7 million for Q1 2026.

• In Q1 2026, Equity Average rose 95.02% year-over-year to $432.7 million; the TTM figure through Mar 2026 stood at $432.7 million (up 95.02% YoY), while the FY2025 annual figure was $306.0 million, up 128.66% from the prior year.
• Equity Average came in at $432.7 million for Q1 2026 at Nutex Health, roughly flat from $430.7 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $432.7 million in Q1 2026 to a low of $79.6 million in Q1 2024.
• A 5-year average of $211.7 million and a median of $134.2 million in 2024 frame the typical range for Equity Average.
• Across the five-year window, Equity Average slumped 70.71% in 2023 and jumped 378.93% in 2025, its largest moves.
• Nutex Health's Equity Average stood at $126.4 million in 2022, then slipped by 27.23% to $92.0 million in 2023, then soared by 45.81% to $134.2 million in 2024, then jumped by 221.07% to $430.7 million in 2025, then rose by 0.47% to $432.7 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $432.7 million, $430.7 million, and $387.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison